Business Context and Reporting Period
This Form 8-K Current Report was filed by MacroGenics, Inc. on July 8, 2026, covering the event date of July 1, 2026. The filing addresses a change in the composition of the Company's Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to corporate governance updates and does not contain financial performance data.
Material Changes
Board Departure: On July 1, 2026, Karen Ferrante, M.D. notified the Board of her resignation, effective September 1, 2026.
- Reason: Personal reasons.
- Disagreement: The resignation was not the result of any disagreement with the Company regarding operations, policies, or practices.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies beyond the standard disclosure regarding the director's departure.
Key Facts for Investor Verification
- Verify the effective date of Dr. Ferrante's resignation (September 1, 2026).
- Confirm whether the Board has initiated a search for a replacement director.
- Review subsequent filings to ensure no undisclosed disagreements arose post-notification.